Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 2.01B | 2.10B | 2.16B | 2.07B | 2.08B | 2.08B |
| Gross profit | 1.10B | 1.14B | 1.18B | 1.11B | 1.17B | 1.14B |
| Research and development | 189M | 183M | 189M | 193M | 189M | 192M |
| Selling, general and administrative | 827M | 780M | 772M | 769M | 701M | 701M |
| Operating expenses | — | — | — | — | 1.81B | 1.84B |
| Operating income | 81M | 1.69B | 214M | 152M | 275M | 244M |
| Pre-tax income | 16M | 1.51B | 103M | 38M | 167M | 96M |
| Income tax | 3M | 248M | 13M | −99M | 45M | 7M |
| Net income | 13M | 1.27B | 90M | 137M | 122M | 89M |
| Earnings per share | 0.07 | 7.26 | 0.52 | 0.79 | 0.70 | 0.51 |
| Earnings per share, diluted | 0.07 | 7.22 | 0.51 | 0.78 | 0.70 | 0.51 |
| Weighted average shares | 174M | 174M | 174M | 174M | 173M | 173M |
| Weighted average shares, diluted | 176M | 175M | 175M | 175M | 174M | 174M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 561M | 878M | 1.64B | 492M | 534M | 762M | 772M | 897M |
| Receivables | 1.06B | 1.03B | 1.02B |
| Metric | 31 Mar 2026 | 31 Mar 2025 |
|---|---|---|
| Operating cash flow | −189M | 29M |
| Depreciation and amortisation | 135M | 129M |
| Share-based compensation | 51M | 49M |
| Capital expenditure | 84M | 109M |
| Investing cash flow | −77M | −114M |
| Share buybacks | 67M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 1.07B |
| 926M |
| 1.04B |
| 1.11B |
| 1.03B |
| Inventory | 1.09B | 1.07B | 1.05B | 962M | 866M | 965M | 953M | 899M |
| Current assets | 3.58B | 3.86B | 4.41B | 3.21B | 3.05B | 3.25B | 3.35B | 3.36B |
| Property, plant and equipment | — | 1.33B | 1.34B | 1.31B | 1.20B | 1.62B | 1.60B | 1.54B |
| Goodwill | 5.63B | 5.70B | 5.26B | 5.27B | 4.99B | 6.38B | 6.59B | 6.45B |
| Total assets | 14.10B | 14.29B | 13.97B | 15.07B | 14.53B | 14.46B | 14.75B | 14.58B |
| Current liabilities | 3.35B | 3.14B | 2.94B | 2.62B | 2.57B | 2.70B | 2.90B | 2.57B |
| Short-term debt | 505M | 0 | 0 | 0 | 100M | 200M | 300M | — |
| Long-term debt | 4.58B | 5.04B | 5.14B | 7.82B | 7.81B | 7.81B | 7.81B | 8.31B |
| Total liabilities | 9.13B | 9.25B | 8.99B | 11.43B | 11.27B | 11.50B | 11.55B | 11.71B |
| Equity | 4.97B | 5.05B | 4.99B | 3.65B | 3.26B | 2.96B | 3.19B | 2.87B |
| Shares outstanding | 174M | 173M | 173M | 173M | 173M | 173M | 173M | 173M |
| Shares issued | 174M | 173M | 173M | 173M | 173M | 173M | 173M | 173M |
| Treasury shares | 922,636 | 0 | — | — | — | — | — | — |
| 0 |
| Financing cash flow | −50M | −139M |